Evaluation of the efficacy and safety of Transdermal fentanyl in patients suffering from chronic cancer pain in an ambulatory setting.

Trial Profile

Evaluation of the efficacy and safety of Transdermal fentanyl in patients suffering from chronic cancer pain in an ambulatory setting.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2009

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 12 Mar 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 12 Mar 2009 Actual patient number (34) added as reported by ClinicalTrials.gov.
    • 12 Mar 2009 Planned end date (1 May 2004) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top